A close relationship between the regulation of the CXCR4/SDF1 axis and PGK1 has been shown for prostate cancer [25], influencing the “angiogenic switch” [25] through the regulation of angiostatin [28]–[30]. This evidence concerns the gene CXCL12 and prostate cancer.